Collection of Tumor Tissue, Blood and Spinal Fluid From Patients With Brain or Spine Tumors

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1128 participants

Study Classification

OBSERVATIONAL

Study Start Date

2000-01-31

Study Completion Date

2009-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to collect samples of brain or spine tumors. Memorial Sloan-Kettering Cancer Center would then store them for use by researchers who study brain or spine cancer and try to find better ways of treating it. We will also collect blood and spinal fluid from patients with brain or spine tumors. The blood and spinal fluids are also used for research studies of cancer and its treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Collection Of Tissue, Blood, and Other Specimens From Patients With Head and Neck Tumors To Study the Causes, Diagnosis, Prevention and Treatment of Cancers

NCT00580203

Head and Neck Cancers

COMPLETED

CNS and Extracranial Tumor Tissues, CSF, and Blood From Patients With Melanoma Brain Metastases

NCT02058953

Melanoma Brain Metastases

COMPLETED

Rare CNS Tumors Outcomes &Risk

NCT03251989

High Grade Meningioma Ependymoma Medulloblastoma +2 more

COMPLETED

Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract

NCT00582647

Esophageal Cancer Bile Duct Neoplasms Gastric Cancer +4 more

ACTIVE_NOT_RECRUITING

Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors

NCT05934630

Anaplastic Astrocytoma Diffuse Brainstem Glioma Glioblastoma Multiforme +15 more

SUSPENDED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The main objective of the protocol is the establishment of a repository of central nervous system (CNS) tumors or metastases to the CNS and related tissues as an invaluable resource for current or future research studies of the etiology, pathogenesis and treatment of human central nervous system tumors. The database will be established through the intra-operative acquisition of brain or spine tumors as well as the collection of blood and spinal fluids from consenting CNS tumor patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primary or Metastatic Central Nervous System (CNS) Tumor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* For acquisition of intra-operative brain or spine tumor specimens, blood specimens and spinal fluid specimens, all patients who undergo surgery for resection or biopsy qualify for inclusion in this protocol.
* If spinal fluid is not accessed as part of the operative procedure, it will not be collected.
* All patients must be under the care of one or more members of the MSKCC CNS disease management team at the time of tissue acquisition. Patients may have been previously diagnosed and/or treated at another institution.
* Subjects are eligible regardless of sex, age or race.
* Parental or guardian consents will be obtained in the case of minors (less than 18 years of age)

Exclusion Criteria

* Patients or their guardians, in case of a minor, may choose to be excluded at any time.
* If a patient, or guardian, decides to withdraw after some or all of the tissues have been collected, such tissues will be destroyed at their request.
* Patients or their guardians will be counseled at the time of obtaining their consent, of the possibility of withdrawing from the protocol.

Eligible Sex

ALL

Accepts Healthy Volunteers

No